THE PATHOLOGY OF MELANOMA:

AN INTERNATIONAL COURSE

APRIL 11 & 12, 2024

// OBJECTIVE

Following the success of our Courses in 2017, 2018, 2020, and 2022 the objective of the Fifth International Melanoma Course in 2024 will continue to stress due diligence and practical diagnosis of melanocytic lesions. We will emphasize the theme of “Acknowledging uncertainty and avoiding over diagnosis of melanoma”, as well as updates of all cutting-edge knowledge on difficult melanocytes lesions relevant to practicing pathologists and clinicians.

This 2024 venue will again include expertise from the SIRIC (Integrated Cancer Research Site at Institut Curie), the WHO 5th Edition Classification of Melanocytic Tumours, the revised MPATH-Dx Classification schema (2023), the MPATH Group, and the International Melanoma Pathology Study Group.

// THE REVISED MPATH-Dx CLASSIFICATION

  • The revised MPATH (Version 2.0) schema provides a simplified two category system for benign melanocytic lesions: Class I. Low-grade and Class II. High-grade lesions. Practical criteria allow for the mapping of all benign melanocytic lesions with diverse terminologies into these categories.
  • The classification of melanoma is refined by the recognition of a low-risk category of T1a melanoma in the new Class III.
  • The schema provides estimates of risk for disease progression and guidelines for practical management.

// THE COURSE PROGRAMME AND CONTENT

  • The Course will consist of didactic lectures and interactive sessions during the two-day program.
  • An approach of practical diagnosis is based on the extensive experience of the international faculty in the Course.
  • The latest advances in ancillary diagnostic techniques including immunohistochemistry and molecular genetics will be emphasized.
  • Particular attention will be given to predictive biomarkers for targeted, immune and checkpoint inhibitors therapies.

List of speakers

Directors

Pr Raymond L. Barnhill

Course Director

Boris Bastian

Pr

Klaus Busam

Pr

David Elder

Pr

Philip LeBoit

Pr

Richard Scolyer

Pr

LIST OF SPEAKERS

Pr Raymond Barnhill,
Institut Curie and University
of Paris Cité, Paris, France,
Director of the Course

Pr Boris Bastian,
University of California
San Francisco, USA

Pr Klaus Busam,
Memorial Sloan Kettering
Cancer Center, New York, USA

Pr Ian Cree,
University College London, United Kingdom

Pr David Elder,
University of Pennsylvania,
Philadelphia, USA

Dr Arnaud de la Fouchardière,
Centre Léon Bérard, Lyon, France

Pr Philip LeBoit,
University of California San Francisco, USA

Dr Claire Lugassy,
Institut Curie, Paris, France

Pr Lori Lowe,
University of Michigan, Ann Arbor, USA

Dr Denis Malaise,
Institut Curie, Paris, France

Dr Alexandre Matet,
Institut Curie and University
of Paris Cité, Paris, France

Pr Richard Scolyer,
Melanoma Institute of Australia
and the University of Sydney,
Sydney, Australia

NON EXHAUSTIVE LIST OF TOPICS